David Bouchey
Stock Analyst at Aegis Capital
(n/a)
# 4,814
Out of 4,966 analysts
6
Total ratings
n/a
Success rate
-60.39%
Average return
Main Sectors:
Stocks Rated by David Bouchey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBFM Sunshine Biopharma | Reiterates: Buy | $15 | $1.44 | +941.67% | 2 | Dec 5, 2024 | |
| STSS Sharps Technology | Initiates: Buy | $105,600 | $13.55 | +779,235.79% | 1 | May 9, 2023 | |
| IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | $10 → $13 | $1.15 | +1,030.43% | 1 | Jan 25, 2023 | |
| RMTI Rockwell Medical | Downgrades: Outperform | $121 | $1.71 | +6,976.02% | 2 | Oct 19, 2018 |
Sunshine Biopharma
Dec 5, 2024
Reiterates: Buy
Price Target: $15
Current: $1.44
Upside: +941.67%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $105,600
Current: $13.55
Upside: +779,235.79%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $1.15
Upside: +1,030.43%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: $121
Current: $1.71
Upside: +6,976.02%